undefined undefined
NaN.000
NaN.00%
Wedbush analyst David Nierengarten reiterates Nuvation Bio (NYSE:NUVB) with a Outperform and maintains $5 price target.
05-15 21:42
TD Cowen analyst Yaron Werber maintained a Buy rating on Nuvation Bio (NUVB – R...
05-15 07:35
加拿大皇家银行:维持Nuvation Bio(NUVB.US)评级,由优于大市调整至优于大市评级, 目标价由4.00美元调整至5.00美元。
04-17 23:01
Nuvation Bio (NUVB) just unveiled an announcement. Nuvation Bio Inc. recently c...
04-11 04:24
转自:澎湃新闻 【编者按】伴随中国科技的发展,中国企业正以全新姿态迈出国门。高质量的制造、先进的科技应用水平,使得中国科技企业有机会在全球市场赢得声誉。如何选择...
04-09 09:18
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a foreign company in the last four months By Doug Young
04-08 23:43
生物制药股Nuvation Bio大涨37.8%,多家大行上调公司评级;受益于第四季度强劲财报,激光雷达传感器制造商Ouster涨34.5%>>
03-28 18:12
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
03-27 20:40
继阿斯利康收购亘喜生物,诺华收购信瑞诺医药后,又一家中国Biotech被国外药企收购。 3月26日,葆元医药发布消息称,已与Nuvation Bio ...
03-27 05:00
BTIG has upgraded Nuvation Bio (NYSE:NUVB) to buy, citing the company’s plans to acquire AnHeart Therapeutics. The investment firm said the deal will provide Nuvation with a potentially best-in-class ...
03-27 01:37